The 19 analysts offering 12-month price forecasts for Jazz Pharmaceuticals PLC have a median target of 202.00, with a high estimate of 250.00 and a low estimate of 172.00. The median estimate represents a +48.62% increase from the last price of 135.92.
The current consensus among 20 polled investment analysts is to Buy stock in Jazz Pharmaceuticals PLC. This rating has held steady since January, when it was unchanged from a Buy rating.Move your mouse over past months for detail
Earnings and Sales Forecasts
Earnings per Share $3.68
Reporting Date Mar 01
Earnings per Share
Move your mouse over a quarter or year to see how estimates have changed over time.